Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations
2018 ◽
Vol 29
◽
pp. viii258
◽
A. Hollebecque
◽
M. Borad
◽
V. Sahai
◽
D.V.T. Catenacci
◽
A. Murphy
◽
...
2018 ◽
Vol 29
◽
pp. viii319-viii320
◽
A. Necchi
◽
D. Pouessel
◽
R. Leibowitz-Amit
◽
A. Flechon
◽
S. Gupta
◽
...
Neal D. Shore
◽
Ekaterine Asatiani
◽
Christine F. Lihou
◽
Huiling Zhen
◽
Sumati Gupta
2020 ◽
Vol 31
◽
pp. S502-S503
M. Schuler
◽
J. Tabernero
◽
C. Massard
◽
G. Vasudeva Iyer
◽
O. Witt
◽
...
2017 ◽
Vol 17
◽
pp. S350-S351
◽
Srdan Verstovsek
◽
Alessandro Rambaldi
◽
Christine Lihou
◽
Huiling Zhen
◽
Andreas Hochhaus
Srdan Verstovsek
◽
Alessandro Rambaldi
◽
Ekaterine Asatiani
◽
Christine F. Lihou
◽
Huiling Zhen
◽
...
Murat Bastepe
◽
Serap Turan
Mariano Rodriguez
◽
María E Rodríguez
1995 ◽
Vol 270
(17)
◽
pp. 10231-10235
◽
Fen Wang
◽
Mikio Kan
◽
Guochen Yan
◽
Jianming Xu
◽
Wallace L. McKeehan
1996 ◽
Vol 271
(10)
◽
pp. 5663-5670
◽
Agnes Estival
◽
Veronique Monzat
◽
Karine Miquel
◽
François Gaubert
◽
Etienne Hollande
◽
...
1995 ◽
Vol 28
(1)
◽
pp. 21-29
◽
Atsushi Shiraishi
◽
Toshiyuki Ishiwata
◽
Tasuku Shoji
◽
Goro Asano
Close
Export Citation Format
Close
Share Document
Close